Copyright
©The Author(s) 2016.
World J Gastroenterol. Mar 14, 2016; 22(10): 2993-3005
Published online Mar 14, 2016. doi: 10.3748/wjg.v22.i10.2993
Published online Mar 14, 2016. doi: 10.3748/wjg.v22.i10.2993
Figure 2 Outcomes of radiofrequency ablation as a first-line treatment for 316 patients with liver cirrhosis and hepatocellular carcinoma.
RFA: Radiofrequency ablation; HCC: Hepatocellular carcinoma; TACE: Transcatheter arterial chemoembolization.
- Citation: Yang W, Yan K, Goldberg SN, Ahmed M, Lee JC, Wu W, Zhang ZY, Wang S, Chen MH. Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment. World J Gastroenterol 2016; 22(10): 2993-3005
- URL: https://www.wjgnet.com/1007-9327/full/v22/i10/2993.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i10.2993